Downloadable Slides


Share

Program Content

Activities

  • MDD Treatment Augmentation
    Beyond the First Line: Navigating the Crossroads of MDD Treatment Switching and Augmentation Strategies
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: April 01, 2024

    Expires: March 31, 2025

  • MDD Adjunct Slides for APPs
    Charting Paths: Evidence-Based Decisions in MDD Treatment Beyond the First Line
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: April 04, 2024

    Expires: April 03, 2025

  • MDD Adjunct Mood Disorders 2024 DL
    Clinical Crossroads: Navigating MDD Treatment Challenges Through Real-World Cases
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: September 10, 2024

    Expires: September 09, 2025

  • MDD FMX 2024 DL
    Elevating Patient Care in MDD: Switching and Augmentation Strategies
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: September 20, 2024

    Expires: September 19, 2025

Faculty

cover img faculity

Michael Asbach, DMSc, PA-C

Associate Director, International Psychiatry
DENT Neurologic Institute
Buffalo, New York

cover img faculity

Joseph F. Goldberg, MD

Clinical Professor of Psychiatry
Icahn School of Medicine at Mount Sinai
New York, New York

cover img faculity

Lisa Harding, MD

Assistant Clinical Professor of Psychiatry
Yale School of Medicine
Medical Director, Mood Institute
Milford, Connecticut

cover img faculity

Terrell D. Holloway, MD

Clinical Instructor
Yale School of Medicine
Department of Psychiatry
New Haven, Connecticut

cover img faculity

Greg W. Mattingly, MD

Associate Clinical Professor, Washington University
President, Midwest Research Group
President, American Professional Society of ADHD and Related Disorders
St Louis, Missouri

Provided by

ProCE Banner

Supporters

Supported by educational grants from AbbVie Inc. and Intra-Cellular Therapies, Inc.

AbbVie Inc.

Intra-Cellular Therapies, Inc.